Medico Intercontinental Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Dilipkumar Shah

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	5yrs
CEO ownership	10.7%
Management average tenure	4.9yrs
Board average tenure	5.2yrs

Recent management updates

Recent updates

CEO

Dilipkumar Shah

5yrs

Tenure

Mr. Dilipkumar Bhogilal Shah has been Chief Executive Officer of Medico Intercontinental Limited since May 29, 2019. Mr. Shah has vast experience of more than 40 years in Pharma Business.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Samir Shah	MD & Director	no data	₹2.40m	44.33% ₹ 195.3m
Dilipkumar Shah	Chief Executive Officer	5yrs	no data	10.74% ₹ 47.3m
Jay Shah	Chief Financial Officer	4.8yrs	₹719.65k	0.51% ₹ 2.2m
Puneeta Sharma	Company Secretary & Compliance Officer	4.9yrs	₹438.19k	no data

4.9yrs

Average Tenure

Experienced Management: 539938's management team is considered experienced (4.9 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Samir Shah	MD & Director	5.8yrs	₹2.40m	44.33% ₹ 195.3m
Tanvi Shah	Non-Executive Chairman	5.8yrs	no data	no data
Ankur Dave	Independent Director	5.2yrs	no data	no data
Swati Shah	Additional Non-Executive Director	5yrs	no data	no data
Priyank Sancheti	Independent Director	1.5yrs	no data	no data

5.2yrs

Average Tenure

Experienced Board: 539938's board of directors are considered experienced (5.2 years average tenure).

Medico Intercontinental Management

Management criteria checks 2/4

Key information

Recent management updates

Less than half of directors are independent

Medico Intercontinental Limited Announces Resignation of Nikul Dipakbhai Shah as Independent Director

MD & Director recently bought ₹926k worth of stock

Medico Intercontinental Limited, Annual General Meeting, Jun 30, 2023

Medico Intercontinental Limited Appoints Priyank L Sancheti as an Additional Independent Director

Medico Intercontinental Limited Approves Regularisation of Nikul Dipakbhai Shah as an Independent Director

Recent updates

Less than half of directors are independent

Medico Intercontinental Limited Announces Resignation of Nikul Dipakbhai Shah as Independent Director

Investor sentiment improves as stock rises 22%

Investor sentiment deteriorates as stock falls 15%

New major risk - Market cap size

Third quarter 2024 earnings released: EPS: ₹1.02 (vs ₹0.94 in 3Q 2023)

Investor sentiment deteriorates as stock falls 17%

Medico Intercontinental Limited to Report Q3, 2024 Results on Feb 14, 2024

Investor sentiment improves as stock rises 16%

MD & Director recently bought ₹926k worth of stock

Second quarter 2024 earnings released: EPS: ₹0.87 (vs ₹2.66 in 2Q 2023)

Medico Intercontinental Limited to Report Q1, 2024 Results on Aug 14, 2023

Medico Intercontinental Limited Approves Final Equity Dividend for the Financial Year 2022-23

Full year 2023 earnings released: EPS: ₹5.61 (vs ₹9.54 in FY 2022)

Medico Intercontinental Limited, Annual General Meeting, Jun 30, 2023

Medico Intercontinental Limited to Report Q4, 2023 Results on May 29, 2023

Investor sentiment improves as stock rises 25%

Third quarter 2023 earnings released: EPS: ₹0.94 (vs ₹2.30 in 3Q 2022)

Investor sentiment improves as stock rises 25%

Medico Intercontinental Limited to Report Q3, 2023 Results on Feb 14, 2023

Second quarter 2023 earnings released: EPS: ₹2.66 (vs ₹2.29 in 2Q 2022)

Medico Intercontinental Limited Appoints Priyank L Sancheti as an Additional Independent Director

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Medico Intercontinental Limited Approves Regularisation of Nikul Dipakbhai Shah as an Independent Director

Investor sentiment improved over the past week

Medico Intercontinental Limited announced that it expects to receive INR 249.787 million in funding

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Medico Intercontinental Limited to Report Q4, 2022 Results on May 28, 2022

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Less than half of directors are independent

Medico Intercontinental Limited Announces Resignation Mr. Hiren Ravindrabhai Shah as Independent Director

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

High number of new directors

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹7.93 (vs ₹7.25 in FY 2020)

Investor sentiment improved over the past week

New 90-day low: ₹35.00

Medico Intercontinental Limited to Report Nine Months, 2021 Results on Feb 12, 2021

New 90-day high: ₹54.35

Market bids up stock over the past week

New 90-day low: ₹28.00

Market pulls back on stock over the past week

Market pulls back on stock over the past week

First quarter earnings released

New 90-day high - ₹48.75

Medico Intercontinental Limited to Report Q1, 2021 Results on Sep 15, 2020

New 90-day high - ₹32.80

Medico Intercontinental Limited announced that it expects to receive INR 52.32025 million in funding

Medico Intercontinental Limited to Report Q4, 2020 Results on Jun 30, 2020

CEO

Tenure

Leadership Team

Average Tenure

Board Members

Average Tenure